Literature DB >> 21735089

Cognitive function in acromegaly: description and brain volumetric correlates.

Caroline Sievers1, P G Sämann, H Pfister, C Dimopoulou, M Czisch, J Roemmler, J Schopohl, G K Stalla, J Zihl.   

Abstract

In acromegaly, we reported on increased rates of affective disorders such as dysthymia and depression, as well as structural brain changes. Objective of this study was to determine if cognitive impairments in patients with acromegaly exist and whether such impairments are associated with structural brain alterations defined by magnetic resonance imaging (MRI). In this cross-sectional study, 55 patients with biochemically confirmed acromegaly were enrolled. MRI data were compared with 87 control subjects. Main outcome measures were performance levels in 13 cognitive tests covering the domains of attention, memory and executive function, with performance below the cut-off level of the 16th percentile rated as impaired. In addition, individual global and hippocampal volume changes were defined for each patient in reference to a normative sample. We found that up to 33.3% of the patients were impaired in the attention, up to 24.1% in the memory, and up to 16.7% in the executive function domain. 67.3% of the patients failed to reach the cut-off level in at least one subtest. MRI demonstrated increased global, left and right hippocampal grey matter and white matter, particularly early in the disease course. Rather few positive than expected negative correlations could be established between the hippocampal grey matter gain and cognitive performance. Cognitive dysfunction, particularly attentional deficits, are common in acromegaly, rendering neuropsychological testing essential in the diagnostic work-up.

Entities:  

Mesh:

Year:  2012        PMID: 21735089     DOI: 10.1007/s11102-011-0326-z

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  24 in total

Review 1.  Patient selection for IGF-I therapy.

Authors:  P E Clayton; O Ayoola; A J Whatmore
Journal:  Horm Res       Date:  2006

2.  Age-sensitive cognitive function, growth hormone and insulin-like growth factor 1 plasma levels in healthy older men.

Authors:  A Aleman; W R de Vries; E H de Haan; H J Verhaar; M M Samson; H P Koppeschaar
Journal:  Neuropsychobiology       Date:  2000-01       Impact factor: 2.328

Review 3.  Serum insulin-like growth factor I in brain function.

Authors:  Eva Carro; Ignacio Torres-Aleman
Journal:  Keio J Med       Date:  2006-06

4.  Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation.

Authors:  Simone Reppermund; Josef Zihl; Susanne Lucae; Sonja Horstmann; Stefan Kloiber; Florian Holsboer; Marcus Ising
Journal:  Biol Psychiatry       Date:  2006-12-22       Impact factor: 13.382

5.  Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly.

Authors:  José Leon-Carrion; Juan Francisco Martin-Rodriguez; Ainara Madrazo-Atutxa; Alfonso Soto-Moreno; Eva Venegas-Moreno; Elena Torres-Vela; Pedro Benito-López; Maria Angeles Gálvez; Francisco J Tinahones; Alfonso Leal-Cerro
Journal:  J Clin Endocrinol Metab       Date:  2010-06-16       Impact factor: 5.958

Review 6.  Insulin-like growth factor-1 in plasma and brain: regulation in health and disease.

Authors:  Caroline Sievers; Harald Jorn Schneider; Gunter Karl Stalla
Journal:  Front Biosci       Date:  2008-01-01

7.  Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire.

Authors:  Susannah V Rowles; L Prieto; X Badia; Steven M Shalet; Susan M Webb; Peter J Trainer
Journal:  J Clin Endocrinol Metab       Date:  2005-03-08       Impact factor: 5.958

Review 8.  Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from > 10,000 patients and review of the literature.

Authors:  Evgeny Shlyakhto
Journal:  Curr Med Res Opin       Date:  2007-11       Impact factor: 2.580

Review 9.  [Somatic factors in cognitive impairment].

Authors:  T Etgen; M Brönner; D Sander; H Bickel; K Sander; H Förstl
Journal:  Fortschr Neurol Psychiatr       Date:  2009-02-16       Impact factor: 0.752

Review 10.  Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain.

Authors:  N David Aberg; Katarina Gustafson Brywe; Jörgen Isgaard
Journal:  ScientificWorldJournal       Date:  2006-01-18
View more
  15 in total

1.  Neuropsychological functioning in acromegaly: towards identification of modifiable factors to improve long-term care after remission.

Authors:  Alberto M Pereira
Journal:  Endocrine       Date:  2015-09-08       Impact factor: 3.633

2.  High Postnatal Growth Hormone Levels Are Related to Cognitive Deficits in a Group of Children Born Very Preterm.

Authors:  Shannon E Scratch; Peter J Anderson; Lex W Doyle; Deanne K Thompson; Zohra M Ahmadzai; Ronda F Greaves; Terrie E Inder; Rodney W Hunt
Journal:  J Clin Endocrinol Metab       Date:  2015-05-14       Impact factor: 5.958

3.  Evaluation of depressive mood and cognitive functions in patients with acromegaly under somatostatin analogue therapy.

Authors:  H Alibas; K Uluc; P Kahraman Koytak; M M Uygur; N Tuncer; T Tanridag; D Gogas Yavuz
Journal:  J Endocrinol Invest       Date:  2017-06-28       Impact factor: 4.256

4.  Perception of health and cognitive dysfunction in acromegaly patients.

Authors:  Iris Crespo; Susan M Webb
Journal:  Endocrine       Date:  2014-03-25       Impact factor: 3.633

5.  Evidence of dysexecutive syndrome in patients with acromegaly.

Authors:  Shaobo Shan; Lingling Fang; Jia Huang; Raymond C K Chan; Guijun Jia; Weiqing Wan
Journal:  Pituitary       Date:  2017-12       Impact factor: 4.107

6.  Neuropsychological care and rehabilitation of cancer patients with chemobrain: strategies for evaluation and intervention development.

Authors:  Pascal Jean-Pierre; Douglas Johnson-Greene; Thomas G Burish
Journal:  Support Care Cancer       Date:  2014-03-27       Impact factor: 3.603

7.  Impaired decision making and delayed memory are related with anxiety and depressive symptoms in acromegaly.

Authors:  Iris Crespo; Alicia Santos; Elena Valassi; Patricia Pires; Susan M Webb; Eugenia Resmini
Journal:  Endocrine       Date:  2015-05-28       Impact factor: 3.633

8.  Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study.

Authors:  Chris G Yedinak; Maria Fleseriu
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

9.  Microstructural brain changes in acromegaly: quantitative analysis by diffusion tensor imaging.

Authors:  R Kilicarslan; M M Ilhan; A Alkan; A Aralasmak; M E Akkoyunlu; L Kart; E Tasan
Journal:  Br J Radiol       Date:  2014-04-16       Impact factor: 3.039

Review 10.  [Diagnostics and treatment of acromegaly : Necessity for targeted monitoring of comorbidities].

Authors:  S Petersenn; M Christ-Crain; M Droste; R Finke; J Flitsch; I Kreitschmann-Andermahr; A Luger; J Schopohl; G Stalla
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.